Stifel Earlier Defended Tango Therapeutics Inc. (TNGX) Amid 12pct Decline

February 26, 2026 1:25 PM UTC Send to a Friend
(Updated - February 26, 2026 1:25 PM EST)

Stifel analyst Laura Prendergast reiterated a Buy rating and $15.00 price ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login